Eisaku Miyauchi

Assistant Professor

Tohoku Daigaku

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eisaku Miyauchi is an Assistant Professor at Tohoku Daigaku Byoin in Japan. His research focuses on the clinical management of non-small cell lung cancer (NSCLC), particularly in the context of targeted therapies and immunotherapies. Recent articles authored by Professor Miyauchi include studies on the monitoring of plasma EGFR mutations, the efficacy of immune checkpoint inhibitors, and the clinical significance of tumor markers in thymic carcinoma.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Naoki Furuya

Ohio State University

UNITED STATES

View details

Kazuhisa Takahashi

Juntendo University Graduate School of Medicine

JAPAN

View details

Kazuya Takeda

adjunct professor

Tohoku University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eisaku Miyauchi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation

Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study

Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study

Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02)

Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice

Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study

Histologic transformation of epidermal growth factor receptor–mutated lung cancer

Urine autotaxin levels reflect the disease activity of sarcoidosis

Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations

Collaborators (3)

Naoki Furuya

Kazuhisa Takahashi

Kazuya Takeda

Make your next move.